TXMD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
TherapeuticsMD Inc (TXMD) is not a strong buy at this moment for a beginner investor with a long-term strategy. While there is insider buying activity and revenue growth, the lack of positive technical signals, poor financial performance in net income and EPS, and no significant news catalysts suggest holding off on this investment for now.
The MACD histogram is negative and contracting (-0.00745), RSI is neutral at 48.499, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot point (2.248) with support at 2.172 and resistance at 2.324. Overall, technical indicators suggest a neutral to slightly bearish outlook.
Insider buying activity has increased by 399.50% over the last month, which could indicate confidence in the company's future.
No recent news or events to drive positive sentiment. Financial performance shows a significant drop in net income (-124.96% YoY) and EPS (-120.00% YoY). The stock has a 50% chance to decline in the short term (-0.35% next day, -3.95% next week, -6.73% next month).
In Q3 2025, revenue increased by 43.33% YoY to $784,000, but net income dropped by -124.96% YoY to $152,000. EPS also declined by -120.00% YoY to 0.01. Gross margin remained flat at 100%.
No recent analyst ratings or price target changes are available for TXMD.
